
Featured article
UCL Honors Dr. Victor Hernandez, Whose Bardet-Biedl Gene Therapy Our Donors Helped Fund
University College London named Dr. Victor Hernandez, co-founder of Axovia Therapeutics, to its 200 Faces. In thanking the people behind his gene therapy for Bardet-Biedl syndrome, he singled out A Race Against Blindness.
Read the article